The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET

Psychopharmacology (Berl). 1999 Jun;144(3):279-81. doi: 10.1007/s002130051004.

Abstract

Rationale: Alterations in 5-HT2A receptor binding are implicated in suicidality and depression. 5-HT2A receptors may also be involved in the therapeutic effects of antidepressants.

Objectives: The purpose of this study was to assess the effect of paroxetine and nefazodone on 5-HT2A receptors after a single dose.

Methods: Seven subjects received a single dose of nefazodone 200 mg and five subjects received a single dose of paroxetine 20 mg. Before and after the dose, 5-HT2A binding potentials (Bmax/Kd) were determined in each subject using [18F]-setoperone PET.

Results: Nefazodone induced a significant change in 5-HT2A binding potential (-39+/-17%,, P = 0.003) while paroxetine showed no significant alteration of 5-HT2A binding potential (+3+/-13%, P = 0.73).

Conclusions: The change in 5-HT2A binding potential seen with nefazodone represents blockade of 5-HT2A receptors by the drug. We do not find evidence for acute downregulation of 5-HT2A receptors with paroxetine within 9 h.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analysis of Variance
  • Antidepressive Agents / pharmacology*
  • Binding, Competitive / drug effects
  • Female
  • Fluorine Radioisotopes
  • Humans
  • Male
  • Paroxetine / pharmacology*
  • Piperazines
  • Pyrimidinones
  • Receptor, Serotonin, 5-HT2A
  • Receptors, Serotonin / metabolism*
  • Tomography, Emission-Computed
  • Triazoles / pharmacology*

Substances

  • Antidepressive Agents
  • Fluorine Radioisotopes
  • Piperazines
  • Pyrimidinones
  • Receptor, Serotonin, 5-HT2A
  • Receptors, Serotonin
  • Triazoles
  • Paroxetine
  • nefazodone
  • setoperone